-
公开(公告)号:EP4335443A1
公开(公告)日:2024-03-13
申请号:EP23172543.3
申请日:2023-05-10
申请人: Renatus Inc.
发明人: KIM, Hee Gon
IPC分类号: A61K31/724 , A61P13/12
摘要: Provided are a method of treating chronic kidney disease or one or more symptoms thereof, or reducing a complication related to chronic kidney disease, the method comprising, administering a therapeutically effective amount of gamma-cyclodextrin oligomer to a subject in need thereof. The gamma-cyclodextrin oligomers are effective in cholesterol metabolism enhancement, cholesterol efflux, reducing inflammatory cytokine secretion, renal clearance of cholesterol and/or reducing albuminuria. Therefore, the gamma-cyclodextrin oligomers can be used to treat or alleviate chronic kidney disease, symptoms thereof and/or a complication related to chronic kidney disease.
-
公开(公告)号:EP4284506A1
公开(公告)日:2023-12-06
申请号:EP22746860.0
申请日:2022-02-01
IPC分类号: A61P25/30 , A61P25/36 , A61K31/485 , A61K31/724 , A61K47/40
-
公开(公告)号:EP4210715A1
公开(公告)日:2023-07-19
申请号:EP21867468.7
申请日:2021-09-08
发明人: LAMBERTO, David, J. , AVALLE, Paolo , CODAN, Lorenzo , LARPENT, Patrick , SCHOELL, Jochen , NEUHAUS, Jeffrey, S.
IPC分类号: A61K31/724 , C08L5/16 , C08B37/00 , A61K31/716
-
公开(公告)号:EP4199936A1
公开(公告)日:2023-06-28
申请号:EP21859232.7
申请日:2021-08-20
发明人: BARNETT, Faith
IPC分类号: A61K31/721 , A61K31/724 , A61K47/69 , A61K47/50 , G01N33/58 , G01N33/60
-
公开(公告)号:EP4157290A1
公开(公告)日:2023-04-05
申请号:EP21818817.5
申请日:2021-06-02
IPC分类号: A61K31/724 , A61P7/10
-
公开(公告)号:EP4115950A1
公开(公告)日:2023-01-11
申请号:EP21763653.9
申请日:2021-03-01
发明人: TERAO Keiji , CHIKAMOTO Keita , FURUNE Takahiro , NANRI Ayumi , YOSHIKAWA Yutaka
IPC分类号: A61P1/00 , A61P1/10 , A61P37/04 , A23L33/125 , A61K31/724
摘要: An agent which can play a comparable or superior role to LS in improvement of intestinal tract function, enhancement of immune function, suppression of production of a putrefactive product, improvement of bowel movement or the like and an agent which can play a role in protection of the intestinal tract from a food emulsifier, a lipid peroxide or the like are provided. An intestinal tract function-improving agent, an immunoenhancing agent, a putrefactive product production-suppressing agent, a bowel movement-improving agent and an intestinal tract protection agent each containing a cyclodextrin as an active ingredient are provided. they can play a comparable or superior role to LS in improvement of intestinal tract function, enhancement of immune function, suppression of production of a putrefactive products, improvement of bowel movement or the like and the agent which can play a role in protection of the intestinal tract from a food emulsifier, a lipid peroxide or the like. Using the agents as an active ingredient, an anti-inflammatory agent, an immunostimulant, a body odor-improving agent, a stool odor-improving agent, a laxative, an intestinal tract protection agent and the like can also be provided.
-
公开(公告)号:EP4023292A1
公开(公告)日:2022-07-06
申请号:EP20859347.5
申请日:2020-06-25
IPC分类号: A61P21/00 , A61K9/08 , A61J1/00 , A61J1/05 , A61K31/724
摘要: [Problem] To provide a sugammadex sodium injection formulation capable of suppressing fluctuations in foreign substances such as analog substances and being stably preserved for a long period of time. [Solution] An injection formulation comprising: a medical container having an oxygen-permeable container, in which a sugammadex sodium aqueous solution containing sugammadex sodium as an active ingredient is filled and under undergoes high pressure steam sterilization; and an oxygen permeation-retardant packaging container, wherein (i) the medical container is accommodated and hermetically sealed, together with an oxygen scavenger, inside the oxygen permeation-retardant packaging container, or (ii) the medical container is accommodated and hermetically sealed inside the oxygen permeation-retardant packaging container, into which an inert gas has been substituted.
-
公开(公告)号:EP4006551A1
公开(公告)日:2022-06-01
申请号:EP22151226.2
申请日:2014-05-07
IPC分类号: G01N33/566 , A61K31/724 , A61P3/06 , C08B37/16
摘要: Various embodiments of the present invention are directed to polyrotaxanes comprising a poloxamer core and at least one cyclodextrin and methods for treating Niemann-Pick type C (NPC) and imaging (e.g., MRI) using the polyrotaxanes various embodiments of the present invention.
-
9.
公开(公告)号:EP3993810A1
公开(公告)日:2022-05-11
申请号:EP20734755.0
申请日:2020-06-30
IPC分类号: A61K31/724 , A61P11/02 , A61K9/00 , A61K47/02
-
10.
公开(公告)号:EP3962963A1
公开(公告)日:2022-03-09
申请号:EP20798132.5
申请日:2020-04-29
申请人: Taka USA, Inc.
IPC分类号: C08B37/16 , A61K31/724
-
-
-
-
-
-
-
-
-